Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Investment is the first phase of the company's ongoing expansion strategy
June 7, 2018
By: Tim Wright
Editor-in-Chief, Contract Pharma
The Wasdell Group has unveiled plans to invest £500,000 in a new laboratory at its Newcastle, UK site. The purpose built 1,200 sq. ft facility will allow Wasdell to offer in-house microbiological and analytical services to its customers and will support the business’ manufacturing, packaging and quality control (QC) teams. The investment into its laboratory capabilities was driven by the company’s growing customer base at its manufacturing facility in Newcastle, as well as an increase in the number of pre-clinical development projects that have recently been awarded to Wasdell. “This latest investment is part of a client-centric strategy that ensures we continue to offer existing and new clients a fast and efficient service that meets their end-to-end supply needs,” said Daniel Tedham, managing director, Wasdell. “We’ve seen a notable increase in demand for analytical support from our existing clients and the investment in our microbiological capabilities has been driven by our planned move into the manufacture of sterile products later this year.” A microbiological laboratory team will deliver in-house environmental monitoring, sample analysis, water testing, microbiological identification analysis, component testing and growth promotion testing. The lab will also offer analytical capabilities for chemical, physical and microbiological analysis including HPLC, FTIR and wet chemistry with QC testing of raw materials, drug substances (currently Schedule III with capacity to cater for Schedule II products) and drug products in accordance with pharmacopoeial monographs and client methods. “The new lab opens the door for further investment in the Newcastle facility, expansion of our on-site QC capabilities and future opportunities for growth to meet our client requirements,” said Mr. Tedham. The investment is the first phase of the company’s ongoing expansion strategy to bolster its laboratory capabilities and ensure seamless internal operations. The second phase will include the opening of a new laboratory facility in Ireland to futureproof Wasdell’s release testing offering for the European market in the event of a hard Brexit. The facility is the latest addition to the company’s manufacturing site in Newcastle. The 26,000 sq. ft facility is MHRA approved for pharmaceutical manufacturing and has a Home Office Controlled Drugs license with on-site storage facilities. It follows the recent announcement of the company’s new €30 million pharmaceutical facility in Dundalk, Ireland, which will offer QC import testing, a variety of current and novel packaging technologies as well as storage and distribution.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !